NASDAQ:FBIOP

Fortress Biotech 9.375 % Cum Conv Perp Red Pfd Registered Shs Series A Stock Forecast

etoro logo Buy FBIOP
*Your capital is at risk
$18.56
-0.240 (-1.28%)
At Close: Jul 10, 2026
AI Analysis AI Analysis of FBIOP AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add FBIOP to Watchlist?
Some Reasons Why To Add FBIOP:
  • +120.7% price growth over the last year
  • Strong return on equity of 163.9%
  • +82.7% YTD performance
PDF

Red day on Friday for Fortress Biotech Inc.9.375 % Cum Conv
(Updated on Jul 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 08, 2026 Loss -2.65%

The Fortress Biotech Inc.9.375 % Cum Conv stock price fell by -1.28% on the last day (Friday, 10th Jul 2026) from $18.80 to $18.56. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 1.90% from a day low at $18.40 to a day high of $18.75. The price has fallen in 6 of the last 10 days and is down by -8.03% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -3 thousand shares and in total, 8 thousand shares were bought and sold for approximately $142.26 thousand.

Given the current short-term trend, the stock is expected to rise 58.22% during the next 3 months and, with a 90% probability hold a price between $29.37 and $39.00 at the end of this 3-month period.

FBIOP Signals & Forecast

There are few to no technical positive signals at the moment. The Fortress Biotech Inc.9.375 % Cum Conv stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $19.60 and $19.71. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 04, 2026, and so far it has fallen -11.95%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Fortress Biotech Inc.9.375 % Cum Conv stock

Fortress Biotech Inc.9.375 % Cum Conv finds support from accumulated volume at $18.24 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the stock. During the last day, the stock moved $0.350 between high and low, or 1.90%. For the last week the stock has had daily average volatility of 3.67%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (FBIOP) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Fortress Biotech Inc.9.375 % Cum Conv Perp Red Pfd Registered Shs Series A to open at $18.57, and during the day (based on 14 day Average True Range), to move between $18.29 and $18.83, which gives a possible trading interval of +/-$0.543 (+/-2.97%) up or down from last closing price. If Fortress Biotech Inc.9.375 % Cum Conv Perp Red Pfd Registered Shs Series A takes out the full calculated possible swing range there will be an estimated 2.97% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $18.24 (1.72%) than the resistance at $19.40 (4.53%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Fortress Biotech Inc.9.375 % Cum Conv Perp Red Pfd Registered Shs Series A stock A Buy?

The Fortress Biotech Inc.9.375 % Cum Conv stock holds several negative signals and despite the positive trend, we believe Fortress Biotech Inc.9.375 % Cum Conv will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.196 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $18.57 ( 0.0539%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

FBIOP Performance

Trading levels for FBIOP

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 18.92 1.94%
R2 18.79 1.22%
R1 18.70 0.774%
Price 18.56
S1 18.44 -0.666%
S2 18.35 -1.11%
S3 18.22 -1.83%

Accumulated Volume Support & Resistance Levels

Level Price
R3 20.48 10.34%
R2 20.43 10.08%
R1 19.40 4.53%
Price 18.56
S1 18.24 -1.72%
S2 16.10 -13.25%
S3 15.01 -19.13%

FBIOP Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 05, 2024 Jun 14, 2024 Jun 30, 2024 $0.195 1.23%
2 May 05, 2024 May 14, 2024 May 31, 2024 $0.195 1.23%
3 Apr 12, 2024 Apr 12, 2024 Apr 30, 2024 $0.195 1.32%
4 Mar 14, 2024 Mar 14, 2024 Mar 31, 2024 $0.195 1.18%
5 Feb 07, 2024 Feb 14, 2024 Feb 29, 2024 $0.195 1.27%

FAQ

What is the symbol for Fortress Biotech Inc.9.375 % Cum Conv Perp Red Pfd Registered Shs Series A Stock and on which exchange is it traded?
The symbol for Fortress Biotech Inc.9.375 % Cum Conv Perp Red Pfd Registered Shs Series A is FBIOP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Fortress Biotech Inc.9.375 % Cum Conv Perp Red Pfd Registered Shs Series A Stock?
The Fortress Biotech Inc.9.375 % Cum Conv stock holds several negative signals and despite the positive trend, we believe Fortress Biotech Inc.9.375 % Cum Conv will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Fortress Biotech Inc.9.375 % Cum Conv Perp Red Pfd Registered Shs Series A Stock?
Fortress Biotech Inc.9.375 % Cum Conv Perp Red Pfd Registered Shs Series A Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Fortress Biotech Inc.9.375 % Cum Conv Perp Red Pfd Registered Shs Series A Stock.

What's the current price of Fortress Biotech Inc.9.375 % Cum Conv Perp Red Pfd Registered Shs Series A Stock?
As of the end of day on the Jul 10, 2026, the price of an Fortress Biotech Inc.9.375 % Cum Conv Perp Red Pfd Registered Shs Series A (FBIOP) share was $18.56.

What is the 52-week high and low for Fortress Biotech Inc.9.375 % Cum Conv Perp Red Pfd Registered Shs Series A Stock?
The 52-week high for Fortress Biotech Inc.9.375 % Cum Conv Perp Red Pfd Registered Shs Series A Stock is $21.43 and the 52-week low is $6.27.

What is the market capitalization of Fortress Biotech Inc.9.375 % Cum Conv Perp Red Pfd Registered Shs Series A Stock?
As of the Jul 10, 2026, the market capitalization of Fortress Biotech Inc.9.375 % Cum Conv Perp Red Pfd Registered Shs Series A is 146.109M.

When is the next earnings date for Fortress Biotech Inc.9.375 % Cum Conv Perp Red Pfd Registered Shs Series A?
The upcoming earnings date for Fortress Biotech Inc.9.375 % Cum Conv Perp Red Pfd Registered Shs Series A is Aug 17, 2026.
Click to get the best stock tips daily for free!
ABOUT FORTRESS BIOTECH INC.9.375 % CUM CONV PERP RED PFD REGISTERED SHS SERIES A
Fortress Biotech 9.375 % Cum Conv Perp Red Pfd Registered Shs Series A
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE